Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Advances in Experimental Medicine and Biology
|
September 29, 1999
MRP expression in acute myeloid leukemia. An update
M Filipits, T Stranzl, G Pohl, et al.
Anticancer Research
|
April 13, 2001
P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients
S Zöchbauer-Müller, M Filipits, M Rudas, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Dexverapamil as resistance modifier in acute myeloid leukaemia
R Pirker, S Zöchbauer, H Kupper, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 30, 1999
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer
D Kandioler-Eckersberger, S Kappel, M Mittlböck, et al.
Blood
|
March 21, 1998
Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia
M Filipits, G Pohl, T Stranzl, et al.
Onkologie
|
February 1, 1989
VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma
P Preis, W Scheithauer, E Fritz, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia
R Pirker, G Pohl, T Stranzl, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Characterization of immunotoxins active against ovarian cancer cell lines
R Pirker, D J FitzGerald, T C Hamilton, et al.
Leukemia
|
January 19, 2000
Drug resistance factors in acute myeloid leukemia: a comparative analysis
M Filipits, T Stranzl, G Pohl, et al.
Anticancer Research
|
March 4, 2000
Expression of the multidrug resistance protein (MRP1) in breast cancer
M Filipits, R Malayeri, R W Suchomel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Advances in Experimental Medicine and Biology
|
September 29, 1999
MRP expression in acute myeloid leukemia. An update
M Filipits, T Stranzl, G Pohl, et al.
Anticancer Research
|
April 13, 2001
P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients
S Zöchbauer-Müller, M Filipits, M Rudas, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1995
Dexverapamil as resistance modifier in acute myeloid leukaemia
R Pirker, S Zöchbauer, H Kupper, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 30, 1999
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer
D Kandioler-Eckersberger, S Kappel, M Mittlböck, et al.
Blood
|
March 21, 1998
Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia
M Filipits, G Pohl, T Stranzl, et al.
Onkologie
|
February 1, 1989
VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma
P Preis, W Scheithauer, E Fritz, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia
R Pirker, G Pohl, T Stranzl, et al.
The Journal of Clinical Investigation
|
September 1, 1985
Characterization of immunotoxins active against ovarian cancer cell lines
R Pirker, D J FitzGerald, T C Hamilton, et al.
Leukemia
|
January 19, 2000
Drug resistance factors in acute myeloid leukemia: a comparative analysis
M Filipits, T Stranzl, G Pohl, et al.
Anticancer Research
|
March 4, 2000
Expression of the multidrug resistance protein (MRP1) in breast cancer
M Filipits, R Malayeri, R W Suchomel, et al.
Page
of 8